An evaluation of service expansion to include patients with heart failure with preserved ejection fraction

Journal article

Peplow, J. and Rees, S. (2024). An evaluation of service expansion to include patients with heart failure with preserved ejection fraction. British Journal of Cardiac Nursing. https://doi.org/10.12968/bjca.2023.0082
AuthorsPeplow, J. and Rees, S.
Abstract

Background/Aims
The Central London Community Healthcare Trust West Hertfordshire heart failure service expanded in 2020 to include patients with heart failure with preserved ejection fraction in addition to the patients with heart failure with reduced ejection fraction. The patient population was predicted to double, requiring staff and
service adjustments; this warranted an evaluation to determine if care targets were maintained. This study aimed to evaluate the impact of service expansion on service
referral rates, length of stay in the service and clinical workload.
Methods
A retrospective quantitative evaluation of the service data from October 2020 to April 2021 was undertaken to compare referral rates, length of stay in service and key
workload metrics between patients with heart failure with reduced ejection fraction and those with heart failure with preserved ejection fraction. All referrals to the service with a new diagnosis of heart failure (confirmed by echocardiogram or magnetic resonance imaging) were considered for evaluation. Of 250 eligible referrals, 81 were selected for inclusion using a random sampling method.
Results
The participants with heart failure with preserved ejection fraction had a median length of stay in the service of 17 weeks. The participants with heart failure with reduced
ejection fraction had a statistically significant longer stay of 35.57 weeks (P<0.001) compared to a pre-expansion length of stay of approximately 17 weeks. Workload was
proportional between the two cohorts. Patients with heart failure with preserved ejection fraction were more likely to be reviewed in multidisciplinary teams or by the consultant
community clinic. This group was less likely to attend clinic, where 96.4% of face-to-face reviews took place at home. Telephone reviews occurred at a similar frequency for both cohorts, comprising 50% of follow ups. The heart failure with reduced ejection fraction cohort required more alterations in medication and medication titration, generating additional follow ups.
Conclusions The service expansion to include patients with heart failure with preserved
ejection fraction has had a significant impact on workload, leading to a reduction in the
quality of care for those with heart failure with reduced ejection fraction.

Year2024
JournalBritish Journal of Cardiac Nursing
PublisherMA Healthcare
ISSN 2052-2207
Digital Object Identifier (DOI)https://doi.org/10.12968/bjca.2023.0082
Publication dates
Print15 Feb 2024
Publication process dates
Accepted16 Dec 2023
Deposited26 Mar 2024
Accepted author manuscript
License
File Access Level
Open
Permalink -

https://openresearch.lsbu.ac.uk/item/96x1y

Download files

Accepted author manuscript
An evaluation of service expansion to include patients with heart failure with preserved ejection fraction.docx
License: CC BY 4.0
File access level: Open

  • 24
    total views
  • 9
    total downloads
  • 0
    views this month
  • 0
    downloads this month

Export as

Related outputs

Sulfasalazine
Rees, Sharon (2024). Sulfasalazine. Journal of Prescribing Practice. 6 (7), pp. 270-271. https://doi.org/10.12968/jprp.2024.6.7.270
Levodopa
Rees, Sharon (2024). Levodopa. Journal of Prescribing Practice. 6 (5), pp. 182-183. https://doi.org/10.12968/jprp.2024.6.5.182
Metronidazole
Rees, S. (2024). Metronidazole. Journal of Prescribing Practice. 6 (4), pp. 138-139. https://doi.org/10.12968/jprp.2024.6.4.138
Oxybutynin
Rees, S. (2024). Oxybutynin. Journal of Prescribing Practice. 6 (2), pp. 50-51. https://doi.org/10.12968/jprp.2024.6.2.50
Vortioxetine
Rees, S. (2024). Vortioxetine. Journal of Prescribing Practice. 6 (1), pp. 6-7. https://doi.org/10.12968/jprp.2024.6.1.6
Drug Breakdown: Colchicine
Rees, Sharon (2023). Drug Breakdown: Colchicine. Journal of Prescribing Practice. 5 (12), pp. 490-491. https://doi.org/10.12968/jprp.2023.5.12.490
Domperidone
Rees, S. (2023). Domperidone. Journal of Prescribing Practice. 5 (11), pp. 446-447. https://doi.org/10.12968/jprp.2023.5.11.446
Drug Breakdown: Fentanyl
Rees, S. (2023). Drug Breakdown: Fentanyl. Journal of Prescribing Practice. 5 (10), pp. 404-404. https://doi.org/10.12968/jprp.2023.5.10.404
Drug breakdown: Bempedoic Acid
Rees, Sharon (2023). Drug breakdown: Bempedoic Acid. Journal of Prescribing Practice. 5 (9), pp. 360-361. https://doi.org/10.12968/jprp.2023.5.9.360
Drug Breakdown: Isotretinoin
Rees, S. (2023). Drug Breakdown: Isotretinoin. Journal of Prescribing Practice. 5 (8), pp. 316-317. https://doi.org/10.12968/jprp.2023.5.8.316
Drug Breakdown: Methylphenidate
Rees, S. (2023). Drug Breakdown: Methylphenidate. Journal of Prescribing Practice. 5 (7), pp. 272-273. https://doi.org/10.12968/jprp.2023.5.7.272
Drug Breakdown: Fosfomycin
Rees, S. (2023). Drug Breakdown: Fosfomycin. Journal of Prescribing Practice. 5 (6), pp. 228-229. https://doi.org/10.12968/jprp.2023.5.6.228
Drug Breakdown: Minoxidil
Rees, Sharon (2023). Drug Breakdown: Minoxidil. Journal of Prescribing Practice. 5 (5), pp. 184-185. https://doi.org/10.12968/jprp.2023.5.5.184
Book Review: Principles and Practice of Nurse Prescribing: Gould and Bain
Rees, S. (2023). Book Review: Principles and Practice of Nurse Prescribing: Gould and Bain. Journal of Prescribing Practice. 5 (4), pp. 172-172. https://doi.org/10.12968/jprp.2023.5.4.172
Drug Breakdown: Infliximab
Rees, S. (2023). Drug Breakdown: Infliximab. Journal of Prescribing Practice. 5 (4), pp. 140-140. https://doi.org/10.12968/jprp.2023.5.4.140
Drug Breakdown: Carbimazole
Rees, Sharon (2023). Drug Breakdown: Carbimazole. Journal of Prescribing Practice. 5 (3), pp. 96-97. https://doi.org/10.12968/jprp.2023.5.3.96
Drug Breakdown: Sitagliptin
Rees, Sharon (2023). Drug Breakdown: Sitagliptin. Journal of Prescribing Practice. 5 (2), pp. 52-53. https://doi.org/10.12968/jprp.2023.5.2.52
Drug Breakdown: Celecoxib
Rees, S. (2023). Drug Breakdown: Celecoxib. Journal of Prescribing Practice. 5 (1), pp. 8-8. https://doi.org/10.12968/jprp.2023.5.1.8
Drug Breakdown: Losartan
Rees, S. (2022). Drug Breakdown: Losartan. Journal of Prescribing Practice. 4 (12), pp. 518-518. https://doi.org/10.12968/jprp.2022.4.12.518
Daptomycin
Rees, Sharon (2022). Daptomycin. Journal of Prescribing Practice. 4 (11), pp. 474-474. https://doi.org/10.12968/jprp.2022.4.11.474
Drug Breakdown: sildenafil (Viagra)
Rees, S. (2022). Drug Breakdown: sildenafil (Viagra). Journal of Prescribing Practice. 4 (10), pp. 422-423. https://doi.org/10.12968/jprp.2022.4.10.422
PENTHROX
Rees, S. (2022). PENTHROX. Journal of Prescribing Practice. 4 (9), pp. 378-378. https://doi.org/10.12968/jprp.2022.4.9.378
Drug Breakdown: Omalizumab
Rees, S. (2022). Drug Breakdown: Omalizumab. Journal of Prescribing Practice. 4 (8), pp. 334-335. https://doi.org/10.12968/jprp.2022.4.8.334
Zopiclone
Rees, S. (2022). Zopiclone. Journal of Prescribing Practice. 4 (7), pp. 290-291. https://doi.org/10.12968/jprp.2022.4.7.290
INDAPAMIDE
Rees, S. (2022). INDAPAMIDE. Journal of Prescribing Practice. 4 (5), pp. 184-185. https://doi.org/10.12968/jprp.2022.4.5.184
What is the value of supplementary prescribing in the 2020s? A dietitian's perspective
Ruddock, N. and Rees, S. (2022). What is the value of supplementary prescribing in the 2020s? A dietitian's perspective. Journal of Prescribing Practice. 4 (5), pp. 194-199. https://doi.org/10.12968/jprp.2022.4.5.194
CAFFEINE
Rees, Sharon (2022). CAFFEINE. Journal of Prescribing Practice. 4 (4), pp. 140-141. https://doi.org/10.12968/jprp.2022.4.4.140
A warfarin-antibiotic drug-drug interaction
Feeney, S., Rees, S. and Modha, R.K. (2022). A warfarin-antibiotic drug-drug interaction. Journal of Prescribing Practice. 4 (4), pp. 156-159. https://doi.org/10.12968/jprp.2022.4.4.156
Quetiapine
Rees, S. (2022). Quetiapine. Journal of Prescribing Practice. 4 (3), pp. 96-96. https://doi.org/10.12968/jprp.2022.4.3.96
ALLOPURINOL
Rees, Sharon (2022). ALLOPURINOL. Journal of Prescribing Practice. 4 (2), pp. 51-51. https://doi.org/10.12968/jprp.2022.4.2.51
NYSTATIN
Rees, S. (2022). NYSTATIN. Journal of Prescribing Practice. 4 (1), pp. 8-8. https://doi.org/10.12968/jprp.2022.4.1.8
CLOPIDOGREL
Rees, Sharon (2021). CLOPIDOGREL. Journal of Prescribing Practice. 3 (12), pp. 474-475. https://doi.org/10.12968/jprp.2021.3.12.474
Sertraline
Rees, S. (2021). Sertraline. Journal of Prescribing Practice. 3 (11), pp. 436-436. https://doi.org/10.12968/jprp.2021.3.11.436
ALENDRONIC ACID
Rees, S. (2021). ALENDRONIC ACID. Journal of Prescribing Practice. 3 (10), pp. 386-386. https://doi.org/10.12968/jprp.2021.3.10.386
DEXAMETHASONE
Rees, S. (2021). DEXAMETHASONE. Journal of Prescribing Practice. 3 (9), pp. 342-342. https://doi.org/10.12968/jprp.2021.3.9.342
Memantine
Rees, S. (2021). Memantine. Journal of Prescribing Practice. 3 (8), pp. 298-298. https://doi.org/10.12968/jprp.2021.3.8.298
Ciprofloxacin
Rees, S. (2021). Ciprofloxacin. Journal of Prescribing Practice. 3 (7), pp. 254-255. https://doi.org/10.12968/jprp.2021.3.7.254
RIVAROXABAN
Rees, S. (2021). RIVAROXABAN. Journal of Prescribing Practice. 3 (6), pp. 210-212. https://doi.org/10.12968/jprp.2021.3.6.210
DAPAGLIFLOZIN
Rees, S. (2021). DAPAGLIFLOZIN. Journal of Prescribing Practice. 3 (5), pp. 166-166. https://doi.org/10.12968/jprp.2021.3.5.166
AZT / ABACAVIR
Rees, S. (2021). AZT / ABACAVIR. Journal of Prescribing Practice. 3 (4), pp. 132-132. https://doi.org/10.12968/jprp.2021.3.4.132
TAMOXIFEN
Rees, S. (2021). TAMOXIFEN. Journal of Prescribing Practice. 3 (3), pp. 96-96. https://doi.org/10.12968/jprp.2021.3.3.96
THEOPHYLLINE
Rees, S. (2021). THEOPHYLLINE. Journal of Prescribing Practice. 3 (2), pp. 52-52. https://doi.org/10.12968/jprp.2021.3.2.52
Drug Breakdown: CARBAMAZEPINE
Rees, Sharon (2021). Drug Breakdown: CARBAMAZEPINE. Journal of Prescribing Practice. 3 (1), pp. 8-9. https://doi.org/10.12968/jprp.2021.3.1.8
FLUCONAZOLE
Rees, S. (2020). FLUCONAZOLE. Journal of Prescribing Practice. 2 (12), pp. 657-657. https://doi.org/10.12968/jprp.2020.2.12.657
DABIGATRAN
Rees, S. (2020). DABIGATRAN. Journal of Prescribing Practice. 2 (11), pp. 564-565. https://doi.org/10.12968/jprp.2020.2.11.564
Drug Breakdown Nitrofurantoin
Rees, S. (2020). Drug Breakdown Nitrofurantoin. Journal of Prescribing Practice. 2 (10). https://doi.org/10.12968/jprp.2020.2.10.526
7 Days of Haloperidol
Rees, S. (2020). 7 Days of Haloperidol. Journal of Prescribing Practice. 2 (9). https://doi.org/10.12968/jprp.2020.2.9.476
Furosemide
Rees, S. (2020). Furosemide. Journal of Prescribing Practice. 2 (4), p. 165. https://doi.org/10.12968/jprp.2020.2.4.165
7 days of mercaptopurine
Rees, S. (2020). 7 days of mercaptopurine. Journal of Prescribing Practice. 2 (1). https://doi.org/10.12968/jprp.2020.2.1.6
7 days of doxycycline
Rees, S. (2020). 7 days of doxycycline. Journal of Prescribing Practice. 2 (5), p. 216. https://doi.org/10.12968/jprp.2020.2.5.216
7 days of hydroxychloroquine
Rees, S. (2020). 7 days of hydroxychloroquine . Journal of Prescribing Practice. 2 (6), p. 268. https://doi.org/10.12968/jprp.2020.2.6.268
CYCLIZINE
Rees, Sharon (2020). CYCLIZINE. Journal of Prescribing Practice. 2 (8), pp. 424-424. https://doi.org/10.12968/jprp.2020.2.8.424
Glyceryl Trinitrate
Rees, S. (2020). Glyceryl Trinitrate. Journal of Prescribing Practice. 2 (7), pp. 372-373. https://doi.org/10.12968/jprp.2020.2.7.372
Sprionolactone
Rees, S. (2019). Sprionolactone. Journal of Prescribing Practice. 1 (12), p. 579. https://doi.org/10.12968/jprp.2019.1.12.579
Higher degrees in nursing: traditional research PhD or professional doctorate?
Rees, S., Ousey, K., Koo, K., Ahmad, N. and Bowling, F. (2019). Higher degrees in nursing: traditional research PhD or professional doctorate? British Journal of Nursing. 28 (14), pp. 940-945. https://doi.org/10.12968/bjon.2019.28.14.940
Drug therapies to manage nausea and vomiting
Rees, SM (2018). Drug therapies to manage nausea and vomiting. Nurse Prescribing. 16 (1), pp. 37-44. https://doi.org/10.12968/npre.2018.16.1.37
Local Antibiotic Delivery Systems: Current and Future Applications for Diabetic Foot Infections.
Markakis, K, Faris, AR, Sharaf, H, Faris, B, Rees, SM and Bowling, FL (2018). Local Antibiotic Delivery Systems: Current and Future Applications for Diabetic Foot Infections. International Journal of Lower Extremity Wounds. 17 (1), pp. 14-21. https://doi.org/10.1177/1534734618757532
Barriers to implementing the Sepsis Six guidelines in an acute hospital setting
Breen, SJ and Rees, SM (2018). Barriers to implementing the Sepsis Six guidelines in an acute hospital setting. British Journal of Nursing. 27 (9), pp. 473-478. https://doi.org/10.12968/bjon.2018.27.9.473
Gabapentin and pregabalin in the pain setting: all you need to know
Rees, SM (2018). Gabapentin and pregabalin in the pain setting: all you need to know. Nurse Prescribing. 16 (7). https://doi.org/10.12968/npre.2018.16.7.332
A practical guide to prescribing statins in primary care
Rees, SM (2018). A practical guide to prescribing statins in primary care. Practice Nursing. 29 (8). https://doi.org/10.12968/pnur.2018.29.8.377
Buprenorphine—an atypical opioid: All you need to know
Rees, SM (2017). Buprenorphine—an atypical opioid: All you need to know. Nurse Prescribing. 15 (8), pp. 402-408. https://doi.org/10.12968/npre.2017.15.8.402
The Perceptions of homeless people regarding their healthcare needs and experiences f receiving healthcare.
Rae, B. and Rees, S. (2015). The Perceptions of homeless people regarding their healthcare needs and experiences f receiving healthcare. Journal of Advanced Nursing. 71 (9), pp. 2096-107. https://doi.org/10.1111/jan.12675